PAC-1

未知生产厂商

PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

PAC-1 has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.

技术标识符

化学式: C₂₃H₂₈N₄O₂
CAS 编号: 315183-21-2
UNII ID: 9LIS8N0B2C

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PAC-1 combination therapy
US 10350207 B2申请人: UNIV ILLINOIS优先权: 2015
CN
US
5 件公开
Combination therapy for the treatment of uveal melanoma
US 12090153 B2申请人: UNIV ILLINOIS优先权: 2018
CN
US
2 件公开
Compound PAC-1 or salt thereof, and medicinal composition containing compound or salt thereof
CN 104910100 A申请人: WANG ZHIMIN优先权: 2014
CN
2 件公开
Isocynate derivatizing agent and methods of production and use
US 6656737 B1申请人: US HEALTH优先权: 2000
US
Fusion anticaries DNA vaccine and prepring method thereof
CN 1419938 A申请人: UNIV WUHAN优先权: 2001
CN
Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2)
US 2007054321 A1申请人: G2 THERAPIES LTD优先权: 2003
US
Use of Metronidazole For Preparing a Pharmaceutical Composition For Treating Pathologies Related to the B-Type Receptor of Interleukin 8 and/or to a Pacap Type 1 Receptor
US 2008221189 A1申请人: GALDERMA RES & DEV优先权: 2004
US
Use Of A Compound Modulating At Least One Receiver Selected In A Group Comprising An Interleukin 8 Type B Receptor And Pacap-1 Receptor For Porparing A Pharmaceutical Composition For Rosacea Treatment
US 2008033060 A1申请人: GALDERMA RES & DEV优先权: 2004
US
Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo
US 2007149439 A1申请人: DICICCO-BLOOM EMANUEL优先权: 2005
US
Low-molecular citrus pectin capable of being combined with clinical common chemotherapeutic drug for controlling cancer and cancer metastasis and diffusion
CN 102085214 A申请人: XIAOQING FAN优先权: 2011
CN

药物